Prescription Dermatological Drugs Global Market Report 2025
상품코드:1720870
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
처방 피부과 치료제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 기간의 성장은 피부 질환의 유병률 증가, 피부과 건강에 대한 의식 증가, 피부과 진찰을 위한 원격 의료 도입 확대, 피부 관리 미용에 대한 수요 증가, 피부과 치료 보험 적용 강화, 맞춤형 의료와 정밀 피부과학에 대한 주목의 고조에 의해 초래될 것으로 예측됩니다.
피부질환의 유병률 증가는 처방 피부과 치료제 시장의 확대를 촉진할 것으로 예측됩니다. 이러한 질환의 증가는 주로 환경 오염 물질에 대한 노출 증가, 생활 방식의 변화, 스트레스 수준의 상승에 기인합니다. 처방 피부과 치료제는 증상을 완화하고 장기적인 피부 건강을 촉진하기 위한 표적 치료를 제공함으로써 이러한 증상을 관리하는데 중요한 역할을 하고 있습니다. Europe PubMed Central은 유럽 27개국에서 실시된 조사에서 약 1억 8,500만 명에 해당하는 참가자의 약 43.35%가 적어도 하나의 피부 질환을 경험하고 있으며, 진균 감염증, 아토피 피부염, 여드름이 가장 많은 것으로 보고되었습니다.
처방 피부과 치료제 시장의 주요 기업은 암메트 메디컬 요구에 대응하고 만성적이고 치료하기 어려운 피부 질환으로 고통받는 환자에게 효과적인 솔루션을 제공하기 위해 결절성 가려움증 치료법과 같은 혁신적인 치료법 개발을 우선합니다. 결절성 가려움증은 강한 가려움, 고조, 딱딱한 결절과 융기를 특징으로 하는 만성 피부 질환입니다. 미국 생명공학 기업인 Regeneron Pharmaceuticals Inc.는 프랑스 제약 기업인 Sanofi S.A.와 협력하여 미국 식품의약국(FDA)으로부터 듀피젠트(두필루맙) 승인을 획득했습니다. 이번 승인은 듀픽센트로 치료받은 환자의 가려움증 중증도와 피부 병변이 위약을 투여받은 환자에 비해 크게 개선된 임상시험 데이터를 기반으로 이루어졌습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 처방 피부과 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 처방 피부과 치료제 시장 : 성장률 분석
세계의 처방 피부과 치료제 시장 실적: 규모와 성장, 2019-2024년
세계의 처방 피부과 치료제 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 처방 피부과 치료제 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 처방 피부과 치료제 시장 : 약제 클래스별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
코르티코스테로이드
레티노이드
칼시뉴린 억제제
항진균제
항생제
기타
세계의 처방 피부과 치료제 시장 : 적응증별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
여드름
건선
피부염
진균성 피부 감염증
기타
세계의 처방 피부과 치료제 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원 약국
소매 약국
온라인 약국
기타
세계의 처방 피부과 치료제 시장 : 코르티코스테로이드별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
국소 코르티코스테로이드
경구 코르티코스테로이드
주사용 코르티코스테로이드
세계의 처방 피부과 치료제 시장 : 레티노이드별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
국소 레티노이드
경구 레티노이드
세계의 처방 피부과 치료제 시장 : 칼시뉴린 억제제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
국소 칼시뉴린 억제제
경구 칼시뉴린 억제제
세계의 처방 피부과 치료제 시장 : 항진균제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
국소 항진균제
경구 항진균제
세계의 처방 피부과 치료제 시장 : 항생 물질별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
국소 항생제
경구 항생제
세계의 처방 피부과 치료제 시장 : 기타 약제 클래스별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
면역억제제
광선요법제
제7장 지역별/국가별 분석
세계의 처방 피부과 치료제 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 처방 피부과 치료제 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
처방 피부과 치료제 시장 : 경쟁 구도
처방 피부과 치료제 시장 : 기업 프로파일
Pfizer Inc.
Johnson & Johnson
Merck KGaA
AbbVie Inc.
Bayer AG
제31장 기타 주요 기업 및 혁신 기업
Novartis AG
GSK plc
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
Intas Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Mylan NV
Sun Pharmaceutical Industries Ltd.
Cipla Limited
Dr. Reddy's Laboratories Ltd.
Zydus Cadila Health Care Limited
Leo Pharma A/S
Glenmark Pharmaceuticals Limited
Almirall SA
DermBiont Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
처방 피부과 치료제 시장, 2029년 : 새로운 기회를 제공하는 국가
처방 피부과 치료제 시장, 2029년 : 새로운 기회를 제공하는 부문
처방 피부과 치료제 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Prescription dermatological drugs are medications prescribed by healthcare providers to treat various skin conditions, including acne, eczema, psoriasis, and other dermatological disorders. These drugs contain active ingredients that require medical supervision to ensure safe and effective use.
The primary drug classes of prescription dermatological drugs include corticosteroids, retinoids, calcineurin inhibitors, antifungal agents, antibiotics, and others. Corticosteroids, which are steroid hormones derived from the adrenal cortex or their synthetic analogs, are primarily used to reduce inflammation and suppress immune responses in various medical conditions. These medications are commonly prescribed for conditions such as acne, psoriasis, dermatitis, and fungal skin infections. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies.
The prescription dermatological drugs market research report is one of a series of new reports from The Business Research Company that provides prescription dermatological drugs market statistics, including the prescription dermatological drugs industry's global market size, regional shares, competitors with a prescription dermatological drugs market share, detailed prescription dermatological drugs market segments, market trends and opportunities, and any further data you may need to thrive in the prescription dermatological drugs industry. This prescription dermatological drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The prescription dermatological drugs market size has grown strongly in recent years. It will grow from $37.77 billion in 2024 to $40.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the increasing prevalence of skin disorders, greater awareness of skin health, the expansion of dermatology clinics, a growing geriatric population, rising healthcare expenditures, and increased investments in research and development.
The prescription dermatological drugs market size is expected to see strong growth in the next few years. It will grow to $52.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period is expected to be driven by the increasing prevalence of skin disorders, rising awareness of dermatological health, expanding telemedicine adoption for dermatology consultations, the growing demand for skincare aesthetics, enhanced insurance coverage for dermatological treatments, and the increasing focus on personalized medicine and precision dermatology. Key trends include the development of targeted biologic therapies, the adoption of gene editing for skin conditions, advancements in drug delivery systems, personalized treatments through genetic profiling, improved absorption in topical medications, and the integration of artificial intelligence to optimize drug formulations and treatment plans.
The growing prevalence of dermatological conditions is expected to drive the expansion of the prescription dermatological drugs market. Dermatological conditions encompass disorders affecting the skin, hair, or nails, such as eczema, psoriasis, and acne, which require medical treatment for effective symptom management. The increasing occurrence of these conditions is largely attributed to heightened exposure to environmental pollutants, lifestyle changes, and rising stress levels. Prescription dermatological drugs play a vital role in managing these conditions by providing targeted treatments to alleviate symptoms and promote long-term skin health. For example, in March 2022, Europe PubMed Central, a UK-based organization hosted by EMBL's European Bioinformatics Institute for biomedical research, reported that a study conducted across 27 European countries found that approximately 43.35% of participants equivalent to around 185 million individuals experienced at least one skin condition, with fungal infections, atopic dermatitis, and acne being the most prevalent. As a result, the increasing prevalence of dermatological conditions is fueling the growth of the prescription dermatological drugs market.
Leading companies in the prescription dermatological drugs market are prioritizing the development of innovative treatments, such as therapies for prurigo nodularis, to address unmet medical needs and provide more effective solutions for patients suffering from chronic and difficult-to-treat skin conditions. Prurigo nodularis is a chronic skin disorder characterized by intensely itchy, raised, and firm nodules or bumps on the skin. For instance, in September 2022, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, partnered with Sanofi S.A., a France-based pharmaceutical company, to secure approval from the U.S. Food and Drug Administration (FDA) for Dupixent (dupilumab). This marks the first and only FDA-approved treatment for prurigo nodularis. The approval was based on clinical trial data demonstrating significant improvements in itch severity and skin lesions in patients treated with Dupixent compared to those receiving a placebo.
In October 2024, Organon & Co., a US-based pharmaceutical company, acquired Dermavant Sciences Ltd. for $1.2 billion. Through this acquisition, Organon aims to expand its dermatology portfolio by incorporating innovative treatments for chronic skin conditions, including prurigo nodularis and psoriasis. Dermavant Sciences Ltd. is a US-based company specializing in the development of therapeutic solutions in immunodermatology.
Major players in the prescription dermatological drugs market are Pfizer Inc., Johnson & Johnson, Merck KGaA, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Mylan NV, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila Health Care Limited, Leo Pharma A/S, Glenmark Pharmaceuticals Limited, Almirall S.A., DermBiont Inc.
North America was the largest region in the prescription dermatological drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in prescription dermatological drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the prescription dermatological drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The prescription dermatological drugs market consists of sales of products such as antifungals, antihistamines, and isotretinoin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Prescription Dermatological Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on prescription dermatological drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for prescription dermatological drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prescription dermatological drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Corticosteroids; Retinoids; Calcineurin Inhibitors; Antifungal Agents; Antibiotics; Other Drug Classes
2) By Indication: Acne; Psoriasis; Dermatitis; Fungal Skin Infections; Other Indications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Subsegments:
1) By Corticosteroids: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids
2) By Retinoids: Topical Retinoids; Oral Retinoids
3) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors; Oral Calcineurin Inhibitors
4) By Antifungal Agents: Topical Antifungals; Oral Antifungals
5) By Antibiotics: Topical Antibiotics; Oral Antibiotics
6) By Other Drug Classes: Immunosuppressants; Phototherapy Agents
Companies Mentioned:Pfizer Inc.; Johnson & Johnson; Merck KGaA; AbbVie Inc.; Bayer AG
3. Prescription Dermatological Drugs Market Trends And Strategies
4. Prescription Dermatological Drugs Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Prescription Dermatological Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Prescription Dermatological Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Prescription Dermatological Drugs Market Growth Rate Analysis
5.4. Global Prescription Dermatological Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Prescription Dermatological Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Prescription Dermatological Drugs Total Addressable Market (TAM)
6.1. Global Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Retinoids
Calcineurin Inhibitors
Antifungal Agents
Antibiotics
Other Drug Classes
6.2. Global Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acne
Psoriasis
Dermatitis
Fungal Skin Infections
Other Indications
6.3. Global Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.4. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Corticosteroids
Oral Corticosteroids
Injectable Corticosteroids
6.5. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Retinoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Retinoids
Oral Retinoids
6.6. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Calcineurin Inhibitors
Oral Calcineurin Inhibitors
6.7. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Antifungal Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Antifungals
Oral Antifungals
6.8. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Antibiotics
Oral Antibiotics
6.9. Global Prescription Dermatological Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunosuppressants
Phototherapy Agents
7. Prescription Dermatological Drugs Market Regional And Country Analysis
7.1. Global Prescription Dermatological Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Prescription Dermatological Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Prescription Dermatological Drugs Market
9.1. China Prescription Dermatological Drugs Market Overview
9.2. China Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Prescription Dermatological Drugs Market
10.1. India Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Prescription Dermatological Drugs Market
11.1. Japan Prescription Dermatological Drugs Market Overview
11.2. Japan Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Prescription Dermatological Drugs Market
12.1. Australia Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Prescription Dermatological Drugs Market
13.1. Indonesia Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Prescription Dermatological Drugs Market
14.1. South Korea Prescription Dermatological Drugs Market Overview
14.2. South Korea Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Prescription Dermatological Drugs Market
15.1. Western Europe Prescription Dermatological Drugs Market Overview
15.2. Western Europe Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Prescription Dermatological Drugs Market
16.1. UK Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.1. Germany Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Prescription Dermatological Drugs Market
18.1. France Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Prescription Dermatological Drugs Market
21.1. Eastern Europe Prescription Dermatological Drugs Market Overview
21.2. Eastern Europe Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Prescription Dermatological Drugs Market
22.1. Russia Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Prescription Dermatological Drugs Market
23.1. North America Prescription Dermatological Drugs Market Overview
23.2. North America Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Prescription Dermatological Drugs Market
24.1. USA Prescription Dermatological Drugs Market Overview
24.2. USA Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Prescription Dermatological Drugs Market
26.1. South America Prescription Dermatological Drugs Market Overview
26.2. South America Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Prescription Dermatological Drugs Market
27.1. Brazil Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Prescription Dermatological Drugs Market
28.1. Middle East Prescription Dermatological Drugs Market Overview
28.2. Middle East Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Prescription Dermatological Drugs Market
29.1. Africa Prescription Dermatological Drugs Market Overview
29.2. Africa Prescription Dermatological Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Prescription Dermatological Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Prescription Dermatological Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Prescription Dermatological Drugs Market Competitive Landscape And Company Profiles
